Chargement en cours...

Metabolism of the aldose reductase inhibitor ALO1567 in man.

1. The metabolism of the aldose reductase inhibitor, ALO1567, was studied in man. The major biotransformation pathway was aromatic hydroxylation followed by glucuronide conjugation. 2. Hydroxylation occurred at several positions on the fluorene ring. The major metabolite was identified as the 7-hydr...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Park, Y H, Hudson, J E, Barker, R C, York, B M, Brazzell, R K
Format: Artigo
Langue:Inglês
Publié: 1991
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC1368447/
https://ncbi.nlm.nih.gov/pubmed/1931471
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!